NA-Epitalon: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 11 sources cited

Overview

N-Acetyl Epitalon is a modified form of Epitalon (epithalon), a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase and is studied for anti-aging properties. The N-acetyl modification is intended to improve bioavailability and resistance to enzymatic degradation, but no published study has tested the modified peptide or compared it with standard Epitalon. It was originally developed based on the work of Dr. Vladimir Khavinson on pineal gland peptide bioregulators.

Mechanism of Action

NA-Epitalon itself has not been studied; its parent peptide Epitalon activates telomerase reverse transcriptase (hTERT) expression in cultured human cells. Telomerase is the enzyme responsible for adding TTAGGG repeat sequences to chromosome ends (telomeres), counteracting the progressive telomere shortening that occurs with each cell division and is associated with cellular senescence and aging. The N-acetyl group is expected to protect the N-terminal alanine from aminopeptidase degradation, but neither this nor better cellular uptake has been tested for this peptide. Beyond telomerase activation, Epitalon has been reported to raise evening melatonin in old monkeys and night melatonin in elderly people with reduced pineal function. It also modulates antioxidant enzyme expression and has demonstrated effects on neuroendocrine regulation in aged animal models.

NA-Epitalon Benefits: What the Research Shows

  • Khavinson et al. (2003) in Bulletin of Experimental Biology and Medicine reported that standard Epitalon activated telomerase and increased telomere length in cultured human fetal fibroblasts
  • A 2003 study in Biogerontology found Epitalon did not change mean lifespan in female SHR mice but extended the lifespan of the longest-lived 10% by 13.3%
  • Research showed Epitalon raised evening melatonin in old rhesus monkeys (Neuroendocrinology Letters, 2001); in isolated rat pineal glands it did not increase melatonin release
  • Anisimov et al. (2001) showed Epitalon reduced spontaneous tumor incidence in female CBA mice; a 2003 study in SHR mice found no change in total tumor incidence
  • Studies in aged human fetal fibroblast cultures showed Epitalon overcame the Hayflick limit, extending replicative capacity by 10 additional population doublings

NA-Epitalon Dosage

  • Standard protocol: 5–10 mg subcutaneous injection daily for 10–20 days
  • Repeat the 10–20 day cycle every 4–6 months
  • Some protocols use 5 mg twice daily (morning and evening) for a 10-day cycle
  • Alternative: 3–5 mg intranasally daily during cycle periods
  • The cyclic dosing pattern mirrors the original Khavinson research protocols
  • Best administered in the evening to align with pineal gland and melatonin production cycles
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

NA-Epitalon Side Effects & Safety

Known Side Effects

  • Injection site irritation — mild redness or soreness, resolving within hours
  • Drowsiness — may occur with evening dosing due to melatonin-stimulating effects
  • Headache — infrequently reported during the first 2–3 days of a cycle
  • No published study has tested N-acetyl Epitalon in animals or humans, and no clinical study has assessed the safety of standard Epitalon
  • Theoretical concern: telomerase activation in pre-cancerous cells could promote growth; the preclinical studies done so far are too limited to rule this out

Safety Profile

Epitalon has been studied for over two decades in Russian biogerontology research, but its N-acetyl form has no published studies of its own. The Khavinson laboratory's animal studies measured lifespan and tumors rather than safety, and FDA found no standard toxicity studies for Epitalon. The primary theoretical concern — that telomerase activation could promote cancer — has not been resolved: several studies showed reduced tumor incidence in Epitalon-treated animals, but FDA considers them too limited to rule out carcinogenic potential. However, individuals with active malignancies should avoid telomerase-activating compounds as a precaution. Long-term human safety data from controlled trials is lacking. Tolerability of the N-acetyl form has not been reported in the literature.

What to Expect

Days 1–5: Improved sleep quality is often the first noticeable effect, attributed to melatonin regulation. Some users report feeling more rested upon waking. No immediate physical changes. Days 5–10: Continued sleep improvement. Some users report improved skin texture and a general sense of well-being. Telomerase activation has been shown only in cultured cells with standard Epitalon, and would not be subjectively perceptible in any case. Post-cycle: Benefits accumulate with repeated cycles over months to years. No published study has measured telomere length in people using either form of Epitalon. The anti-aging effects are best understood as a long-term investment rather than an acute intervention.

Common Stacks

Storage & Handling

Store lyophilized powder at -20°C for long-term storage (up to 24 months) or 2–8°C for up to 6 months. Reconstitute with bacteriostatic water. After reconstitution, refrigerate at 2–8°C and use within 3–4 weeks. The N-acetyl modification is intended to improve stability versus standard Epitalon, though this has not been tested; cold chain storage is still recommended. Protect from light.

Pricing & Available Variants

$45price range
10mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

  1. Araj SK, Brzezik J, Mądra-Gackowska K, et al. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025.
  2. FDA Briefing Document, Pharmacy Compounding Advisory Committee Meeting, July 23-24, 2026: Epitalon-Related Bulk Drug Substances (Epitalon (Free Base) and Epitalon Acetate). U.S. Food and Drug Administration. 2026.
  3. Jain A, Gallacher DM, Issa MA, et al. Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence. Int J Mol Sci. 2026.
  4. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003.
  5. Khavinson VKh, Bondarev IE, Butyugov AA, et al. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med. 2004.
  6. Anisimov VN, Khavinson VKh, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003.
  7. Anisimov VN, Khavinson VK, Mikhalski AI, et al. Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice. Mech Ageing Dev. 2001.
  8. Khavinson V, Goncharova N, Lapin B. Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys. Neuro Endocrinol Lett. 2001.
  9. Korkushko OV, Lapin BA, Goncharova ND, et al. Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people. Adv Gerontol. 2007.
  10. Djeridane Y, Khavinson VKh, Anisimov VN, et al. Effect of a synthetic pineal tetrapeptide (Ala-Glu-Asp-GLy) on melatonin secretion by the pineal gland of young and old rats. J Endocrinol Invest. 2003.
  11. Kozina LS, Arutjunyan AV, Khavinson VKh. Antioxidant properties of geroprotective peptides of the pineal gland. Arch Gerontol Geriatr. 2007.

Related Peptides

Track NA-Epitalon in Your Protocol

Log your NA-Epitalon doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free